Technology
Health
Biotechnology

Strongbridge Biopharma

$2.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-3.61%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SBBP and other stocks, options, ETFs, and crypto commission-free!

About SBBP

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. Read More The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA.

Employees
Headquarters
Lower Southampton, Pennsylvania
Founded
2015
Market Cap
150.05M
Price-Earnings Ratio
3.12
Dividend Yield
0.00
Average Volume
122.32K
High Today
$2.97
Low Today
$2.65
Open Price
$2.79
Volume
90.70K
52 Week High
$6.55
52 Week Low
$2.65

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2015 IPO
US
North America

SBBP Earnings

-$0.49
-$0.41
-$0.33
-$0.25
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.